<?xml version="1.0" encoding="UTF-8"?>
<ref id="bibr20-1759720X20947296">
 <label>20</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Praveen</surname>
    <given-names>D</given-names>
   </name>
   <name>
    <surname>Puvvada</surname>
    <given-names>RC</given-names>
   </name>
   <name>
    <surname>Vijey Aanandhi</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Janus kinase inhibitor baricitinib is not an ideal option for management of COVID-19</article-title>. 
  <source>Int J Antimicrob Agents</source>
  <year>2020</year>; 
  <volume>55</volume>: 
  <fpage>105967</fpage>.
  <pub-id pub-id-type="pmid">32259575</pub-id>
 </mixed-citation>
</ref>
